
On April 17, 2010, scientists from academia, the National Cancer Institute zzso and the Food and Drug Administration zzso assembled at zzso zzso Image zzso Drug zzso zzso in Washington zzso to discuss recent advances, zzso opportunities, and regulatory issues related to the zzso The meeting included a scientific session and an zzso session, followed by a panel discussion of speakers from both zzso zzso drug delivery zzso in cancer is a form of individualized therapy where imaging methods are used in guidance and monitoring of localized and targeted delivery of zzso to the zzso So, a systematic approach to zzso requires mechanisms for zzso delivery, zzso and monitoring of the zzso Although the goal in zzso is to zzso the therapeutic ratio through personalized zzso treatments, a major challenge is in overcoming the biological barriers to the delivery of zzso into tumors and zzso zzso discussed potential challenges to clinical translation of zzso drug delivery systems including in zzso characterization of zzso zzso validation of targeting and delivery, studies of zzso zzso zzso and toxicity as well as zzso manufacturing of delivery zzso zzso and quantitative imaging techniques may serve as enabling tools that could potentially transform many existing challenges into opportunities for advancement of the zzso 

